New Immunotherapy Targets Cancer Resistance Mutations for Broader Treatment

Researchers have discovered a novel method to combat drug-resistant cancers by leveraging the very mutations that cause resistance. This approach, led by Israel's Weizmann Institute, uses a computational tool to identify shared cancer-specific neo-antigens for new immunotherapies.

Read the full story on Quick Digest